Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at Transcatheter Cardiovascular Therapeutics, taking place at the Colorado Convention Center in Denver, Colorado, 29 October – 2 November.
Clinical Adviser, Professor Bruno Scheller MD, will present CathHELIX: A Novel Transcatheter Mitral Valve Repair System as part of the Interventional Innovation III: Emerging Devices and Technological Concepts Session between 10.40 – 14.20 MDT on 1 November 2017. The presentation will take place in the Mile High Ballroom 2A-3A, Ballroom Level, Colorado.
Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.